Impact of inactivated SARS-CoV-2 vaccination on embryo ploidy: a retrospective cohort study of 133 PGT-A cycles in China
暂无分享,去创建一个
Jia Chen | Jiaying Lin | Jialyu Huang | Huijun Zuo | Hancheng Fan | Lingling Huang | Leizhen Xia | Qiongfang Wu | Lifeng Tian | Xingwu Wu | Peipei Liu | Dingfei Xu | Xiaoyan Ai | Mengxi Li | Genbao Xing | Ke Zhang
[1] Yasmin Shibli Abu-Raya,et al. Does mRNA SARS‐CoV‐2 vaccine in the follicular fluid impact follicle and oocyte performance in IVF treatments? , 2022, American journal of reproductive immunology.
[2] M. A. Castiglione Morelli,et al. Are the Follicular Fluid Characteristics of Recovered Coronavirus Disease 2019 Patients Different From Those of Vaccinated Women Approaching in vitro Fertilization? , 2022, Frontiers in Physiology.
[3] Jiaying Lin,et al. No Effect of Inactivated SARS-CoV-2 Vaccination on in vitro Fertilization Outcomes: A Propensity Score-Matched Study , 2022, Journal of inflammation research.
[4] Jialyu Huang,et al. Hormonal Replacement Treatment for Frozen-Thawed Embryo Transfer With or Without GnRH Agonist Pretreatment: A Retrospective Cohort Study Stratified by Times of Embryo Implantation Failures , 2022, Frontiers in Endocrinology.
[5] E. Papaleo,et al. COVID-19 Vaccination Does Not Affect Reproductive Health Parameters in Men , 2022, Frontiers in Public Health.
[6] C. Hernandez-Nieto,et al. In Vitro Fertilization and Early Pregnancy Outcomes After Coronavirus Disease 2019 (COVID-19) Vaccination , 2022, Obstetrics and gynecology.
[7] R. Machtinger,et al. The effect of coronavirus disease 2019 immunity on frozen-thawed embryo transfer cycles outcome , 2022, Fertility and Sterility.
[8] B. Reubinoff,et al. BNT162b2 mRNA Covid-19 vaccine does not impair sperm parameters , 2021, medRxiv.
[9] D. Abramovich,et al. SARS-CoV-2 infection negatively affects ovarian function in ART patients , 2021, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.
[10] O. Lebovitz,et al. Does mRNA SARS-CoV-2 vaccine detrimentally affect male fertility, as reflected by semen analysis? , 2021, Reproductive BioMedicine Online.
[11] P. Dormitzer,et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months , 2021, The New England journal of medicine.
[12] M. Bahmanyar,et al. Vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis post COVID-19 vaccination; a systematic review , 2021, Journal of the Neurological Sciences.
[13] J. Qu,et al. Inactivated SARS-CoV-2 vaccine does not influence the profile of prothrombotic antibody nor increase the risk of thrombosis in a prospective Chinese cohort , 2021, Science Bulletin.
[14] R. Ramasamy,et al. COVID‐19 vaccine hesitancy linked to increased internet search queries for side effects on fertility potential in the initial rollout phase following Emergency Use Authorization , 2021, Andrologia.
[15] R. Ramasamy,et al. Sperm Parameters Before and After COVID-19 mRNA Vaccination. , 2021, JAMA.
[16] R. Morris. SARS-CoV-2 spike protein seropositivity from vaccination or infection does not cause sterility , 2021, F&S Reports.
[17] M. Hassany,et al. Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: A Randomized Clinical Trial. , 2021, JAMA.
[18] R. Nahum,et al. Does mRNA SARS-CoV-2 vaccine influence patients' performance during IVF-ET cycle? , 2021, Reproductive Biology and Endocrinology.
[19] H. Fennema,et al. Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19 , 2021, The New England journal of medicine.
[20] D. Wolf,et al. Ovarian follicular function is not altered by SARS–CoV-2 infection or BNT162b2 mRNA COVID-19 vaccination , 2021, medRxiv.
[21] Yan Liu,et al. Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials , 2021, The Lancet Infectious Diseases.
[22] Gareth Iacobucci. Covid-19: No evidence that vaccines can affect fertility, says new guidance , 2021, BMJ.
[23] A. Yaghoubi,et al. COVID-19 vaccine: where are we now and where should we go? , 2021, Expert review of vaccines.
[24] J. Llácer,et al. Effect of ovarian stimulation on embryo aneuploidy and mosaicism rate , 2021, Systems biology in reproductive medicine.
[25] OUP accepted manuscript , 2021, Human Reproduction.
[26] Crystal Chan,et al. Preimplantation genetic testing for aneuploidy: A Canadian Fertility and Andrology Society Guideline. , 2020, Reproductive biomedicine online.
[27] G. Patounakis,et al. A multicenter, prospective, blinded, nonselection study evaluating the predictive value of an aneuploid diagnosis using a targeted next-generation sequencing-based preimplantation genetic testing for aneuploidy assay and impact of biopsy. , 2020, Fertility and sterility.
[28] Y. Hu,et al. Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial , 2020, The Lancet.
[29] T. Ye,et al. Efficacies of different ovarian hyperstimulation protocols in poor ovarian responders classified by the POSEIDON criteria , 2020, Aging.
[30] C. E.. WHO Coronavirus Disease (COVID-19) Dashboard , 2020 .
[31] J. Swain. Controversies in ART: can the IVF laboratory influence preimplantation embryo aneuploidy? , 2019, Reproductive biomedicine online.
[32] Xuefeng Lu,et al. Anti-müllerian Hormone for the Prediction of Ovarian Response in Progestin-Primed Ovarian Stimulation Protocol for IVF , 2019, Front. Endocrinol..
[33] James H. Crichton,et al. Oocyte development, meiosis and aneuploidy , 2015, Seminars in cell & developmental biology.
[34] M. Benkhalifa,et al. From global proteome profiling to single targeted molecules of follicular fluid and oocyte: contribution to embryo development and IVF outcome , 2015, Expert review of proteomics.
[35] R. Krisher,et al. Oocyte environment: follicular fluid and cumulus cells are critical for oocyte health. , 2015, Fertility and sterility.
[36] F. Kokocinski,et al. Application of next-generation sequencing technology for comprehensive aneuploidy screening of blastocysts in clinical preimplantation genetic screening cycles. , 2014, Human reproduction.
[37] D. Griffin,et al. The origin, mechanisms, incidence and clinical consequences of chromosomal mosaicism in humans. , 2014, Human reproduction update.
[38] Y. Shoenfeld,et al. Infections and vaccines in the etiology of antiphospholipid syndrome , 2012, Current opinion in rheumatology.
[39] M. Eijkemans,et al. Milder ovarian stimulation for in-vitro fertilization reduces aneuploidy in the human preimplantation embryo: a randomized controlled trial. , 2007, Human reproduction.
[40] L. Regan,et al. Antiphospholipid antibodies and infertility , 2002, Human fertility.
[41] Dk Gardner,et al. In-vitro culture of human blastocysts , 1999 .